Electra Therapeutics, Inc. ETRA
8.59 USD -0.25 (-2.83%)
As ofNov 16, 2026, 12:54 PM EST
8.59 Day range 9.27
6.87 52-week range 15.50
- YTD
- -35.17%
- 1 year
- -35.17%
- Market cap
- 539.17M
- EPS (ttm)
- -2.65
- YTD return
- -35.17%
- 1-year return
- -35.17%
- Volume
- 163.55K
- Avg volume
- 582.60K
- Open
- 8.82
- Previous close
- 8.84
- Day's range
- 8.59 – 9.27
- 52-week range
- 6.87 – 15.50
5D +0.88 (+11.06%)
Fundamental scorecard
3 of 25 checks passed on ETRA’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
ETRA Revenue — quarterly 0
ETRA Net income — quarterly -23.93M
ETRA EPS — quarterly -3.47
News
Electra Therapeutics Q3 EPS $(3.47) Misses $(2.72) Estimate
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights
This FirstEnergy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday HC Wainwright & Co. Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $30
12 Health Care Stocks Moving In Friday's Pre-Market Session Star Therapeutics Announces $200M Private Financing To Support Its Pipeline Of Potential Best-in-Disease Therapies
JP Morgan Initiates Coverage On Electra Therapeutics with Overweight Rating, Announces Price Target of $36
Your note
Sign in to keep a note on ETRA — it syncs with the Stock Master app.
